American College of Cardiology: Semaglutide Improves Heart Health Outcomes Beyond Weight Loss
August 31, 2024
August 31, 2024
WASHINGTON, Aug. 31 (TNSres) -- The American College of Cardiology issued the following news release:
* * *
Suite of new sub-studies show the drug is positively impacting cardiovascular health in high-risk patients
* * *
LONDON (Aug 30, 2024) - Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious C . . .
* * *
Suite of new sub-studies show the drug is positively impacting cardiovascular health in high-risk patients
* * *
LONDON (Aug 30, 2024) - Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing serious C . . .